Serum levels of soluble programmed death protein 1 (sPD-1) and soluble programmed death ligand 1 (sPD-L1) in advanced pancreatic cancer-Reference-Cited by-同舟云学术

Serum levels of soluble programmed death protein 1 (sPD-1) and soluble programmed death ligand 1 (sPD-L1) in advanced pancreatic cancer

Published:2017-05-04 Issue:5 Volume:6 Page:e1310358
ISSN:2162-402X
Container-title:OncoImmunology
language:en
Short-container-title:OncoImmunology

Author:

Kruger Stephan¹,Legenstein Marie-Louise¹,Rösgen Verena¹,Haas Michael¹,Modest Dominik Paul¹²,Westphalen Christoph Benedikt¹,Ormanns Steffen³,Kirchner Thomas²³,Heinemann Volker¹²,Holdenrieder Stefan⁴⁵,Boeck Stefan¹²

Affiliation:

1. Department of Internal Medicine III and Comprehensive Cancer Center, Klinikum Grosshadern, Ludwig-Maximilians-University of Munich, Munich, Germany

2. DKTK, German Cancer Consortium, German Cancer Research Center (DKFZ), Heidelberg, Germany

3. Institute of Pathology, Ludwig-Maximilians-University of Munich, Munich, Germany

4. Institute of Laboratory Medicine, German Heart Centre Munich, Technical University of Munich, Munich, Germany

5. Institute of Clinical Chemistry and Clinical Pharmacology, University Hospital Bonn, Bonn, Germany

Publisher

Informa UK Limited

Subject

Oncology,Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/2162402X.2017.1310358

Reference39 articles.

1. Cancer statistics, 2015

2. Projections of cancer incidence and cancer‐related deaths in Germany by 2020 and 2030

3. FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer

4. Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine

5. The Pancreas Cancer Microenvironment

Cited by 113 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prognostic significance of soluble PD-L1 in prostate cancer;Frontiers in Immunology;2024-07-11

2. PD-1/PD-L1 axis: implications in immune regulation, cancer progression, and translational applications;Journal of Molecular Medicine;2024-06-27

3. Development of a microcantilever-based biosensor for detecting Programmed Death Ligand 1;Saudi Pharmaceutical Journal;2024-06

4. Soluble immune checkpoints: implications for cancer prognosis and response to immune checkpoint therapy and conventional therapies;Journal of Experimental & Clinical Cancer Research;2024-05-31

5. PD-1/CD80+ small extracellular vesicles from immunocytes induce cold tumours featured with enhanced adaptive immunosuppression;Nature Communications;2024-05-08